DeepSynopsis has joined NVIDIA Inception program, a program that nurtures startups revolutionizing industries with technological advancements.
DeepSynopsis is an AI-powered clinical intelligence platform designed exclusively for healthcare professionals (HCPs). The platform delivers evidence-based insights, drug interaction guidance, specialty-specific protocols, and real-time clinical support—empowering doctors to make accurate and timely decisions. Integrated with the MedSynapse ecosystem, DeepSynopsis serves a global community of over 1.5 million HCPs across 80 specialties.
“We built DeepSynopsis to eliminate noise and provide doctors with clear, evidence-based clinical answers when they need them the most,” said Phanish Chandra, Founder & CEO at DeepSynopsis. “Being part of NVIDIA Inception allows us to supercharge our AI capabilities and continue pushing the boundaries of intelligent healthcare solutions.”
NVIDIA Inception helps startups during critical stages of product development, prototyping, and deployment. Every Inception member receives a tailored set of ongoing benefits, including NVIDIA Deep Learning Institute credits, preferred pricing on NVIDIA hardware and software, and expert-level technology assistance—equipping startups like DeepSynopsis with the tools they need to scale and succeed.
About DeepSynopsis
DeepSynopsis is an AI-powered clinical intelligence platform designed exclusively for licensed healthcare professionals (HCPs). With the rapid expansion of medical research and the growing complexity of clinical guidelines, doctors often face an overwhelming amount of information when making patient care decisions. DeepSynopsis addresses this challenge by delivering evidence-based, reference-backed insights that are concise, relevant, and clinically actionable.
Unlike generic AI tools, DeepSynopsis is built on a reverse-retrieval architecture (reverse-RAG), ensuring its answers are context-aware and free from unnecessary noise. The platform is particularly valued by clinicians for its ability to:
- Provide drug interaction checks and accurate dosing guidance.
- Summarize the latest research and specialty-specific guidelines.
- Offer quick, evidence-based answers for clinical decision-making
Future Plans and Vision
With the support of NVIDIA Inception, DeepSynopsis is expanding its capabilities to address the evolving needs of healthcare professionals. Future developments include:
- Enhanced AI recommendation systems tailored to specific specialties and patient scenarios.
- Deeper integration with MedSynapse’s global HCP network to deliver real-time insights on trends and clinical guidelines.
- New analytics dashboards to help hospitals, researchers, and pharma companies better understand HCP engagement and clinical data patterns.
By combining AI-driven precision with evidence-based intelligence, DeepSynopsis aims to redefine how clinical knowledge is accessed and applied, ultimately improving patient outcomes and healthcare efficiency.
Legal Attribution
© 2025 NVIDIA, the NVIDIA logo are trademarks and/or registered trademarks of NVIDIA Corporation in the U.S. and other countries.
